FindTrial
Sign In

Effect of GIRK2 and EAAT2 gene polymorphism on pain perception and opioid consumption in patients with herpes zoster pain

Effect of GIRK2 and EAAT2 gene polymorphism on pain perception and opioid consumption in patients with herpes zoster pain

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR1800016962
Enrollment
Unknown
Registered
2018-07-04
Start date
2018-07-05
Completion date
Unknown
Last updated
2018-09-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

herpes zoster

Interventions

Case series:Nil

Sponsors

Xuzhou Medical University Affiliated Hospital
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 90 Years

Inclusion criteria

Inclusion criteria: 1. Patients diagnosed with herpes zoster; 2. Aged 18 to 90 years old, male or female; 3. The communication is accessible and does not affect the assessment.

Exclusion criteria

Exclusion criteria: 1. Central nervous system diseases or mental diseases; 2. Opioid addiction history; 3. the sudden deterioration of the condition; 4. suffering from serious cardiovascular and cerebrovascular diseases; 5. sudden other acute diseases; 6. can not self-evaluators; 7. Participate in other drug testers 3 months before the selection.

Design outcomes

Primary

MeasureTime frame
Visual Analogue scale;Opioid dosage;—

Countries

China

Contacts

Public ContactShen Wen

Xuzhou Medical University

shenwen1598@sina.com+86 18052268689

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026